Bank of America sets Corona bond issuance in motion

Bank of America sets Corona bond issuance in motion

Bank of America becomes the first commercial bank to fight against the virus

Yesterday, Bank of America sold $1 billion worth of corporate bonds, being the first commercial bank to specifically finance the health industry to help it fight the pandemic.

The bank stated that all the proceedings would go to hospitals that treat patients with Covid-19, businesses that make or supply equipment necessary against the virus, and of course, to companies that produce tests or vaccines.

Although it is the first commercial bank to do so, it is not the first to start this movement. Globally, borrowers raised $102.6 billion of debt only this year to combat the impact of the virus. Chinese companies released the Pandemic Bonds, while Paraguay and Kookmin Bank sold debt in U.S. Dollars for Coronavirus relief.

Pfizer issued a $1.25 billion bond used for funding social and environmental attempts, part of it focusing on the pandemic. USAA Capital Corp. sold an $800 million sustainability bond.

According to HSBC, the social and sustainability bond issuance can double this year. The supply gained 69% after the African Development Bank, and the International Finance Corporation sold some of those.

Even though it gained 4.02% during yesterday’s trading session, Bank of America's stock price is 40% lower than last year.

See the difference when trading with CAPEX.com by accessing elite features:

  • Stellar custom service
  • Powerful WebTrader platform and mobile app
  • High-end integrated trading tools
  • Full license and regulation from top regulators

Sources: marketwatch.com, cnbc.com, yahoo.com

The information presented herein is prepared by CAPEX.com and does not intend to constitute Investment Advice. The information herein is provided as a general marketing communication for information purposes only and as such it has not been prepared in accordance with legal requirements designed to promote the independence of investment research, and it is not subject to any prohibition on dealing ahead of the dissemination of investment research.

Users/readers should not rely solely on the information presented herewith and should do their own research/analysis by also reading the actual underlying research. The content herewith is generic and does not take into consideration individual personal circumstances, investment experience or current financial situation.

Therefore, Key Way Investments Ltd shall not accept any responsibility for any losses of traders due to the use and the content of the information presented herein. Past performance is not a reliable indicator of future results.